Ekawat, Hemophilia, Thailand
Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, rare blood disorders, neurology, immunology, and oncology. It helps people with debilitating and complex conditions that are often difficult to diagnose and treat, and is dedicated to discovering and advancing new therapies, providing hope to patients and their families worldwide.
Sanofi Genzyme’s ambition is to be the industry leader in specialty care. Its approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities.
Focus areas
Our Stories
Inspired by Rare Disease Patients Around the World
The Impact of COVID-19 on Cancer
Inside Sanofi’s Hemophilia Research
The Type 2 Inflammation Connection
Adjusting to Life with Multiple Myeloma: Bernard’s Story
Follow Sanofi Genzyme
